Since, elucidating regulatory roles of IgE ICs for the treatment of allergy, asthma, and eosinophil-related diseases requires animal testing first, only clinical data for the treatment of asthma would be for the anti-IgE antibodies. This evidence concerns the gene IGHE and Allergy.